Related Experiment Videos
Successful thrombolysis for prosthetic pulmonary valve obstruction
J A Lopez1, N E Strickman, B S Jin
1Department of Adult Cardiology, Texas Heart Institute, Houston, USA.
Texas Heart Institute Journal
|January 1, 1995
Summary
Systemic thrombolysis is a viable alternative for prosthetic heart valve thrombosis. Intravenous streptokinase successfully treated a St. Jude Medical valve thrombosis after pulmonary valve replacement.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Thrombotic Disorders
Background:
- Prosthetic heart valve surgery carries a risk of thrombosis, a serious complication.
- Systemic thrombolysis is an emerging alternative to surgical intervention for valve thrombosis.
- Limited clinical experience exists regarding the management of pulmonary prosthetic valve thrombosis.
Observation:
- A case of thrombosis involving a St. Jude Medical prosthetic valve is presented.
- The patient had undergone pulmonary valve replacement 3 weeks prior to the observation of thrombosis.
- The thrombosis occurred in the context of a prosthetic pulmonary valve.
Findings:
- Successful administration of intravenous streptokinase was achieved.
- The treatment targeted the thrombosis of the St. Jude Medical prosthetic valve.
- This represents a case of successful non-surgical management of pulmonary valve thrombosis.
Implications:
- Intravenous streptokinase can be an effective treatment for prosthetic pulmonary valve thrombosis.
- This case expands the understanding of thrombolytic therapy in prosthetic valve complications.
- Further research into systemic thrombolysis for pulmonary valve thrombosis is warranted.